|
|
Post by radgray68 on Sept 17, 2021 16:21:33 GMT -5
The “Dragon Snout Club” is starting their squeeze!
I was wondering when they’d show.
I kid, but it’s hard to believe we won’t see ANY volatility as we near PDUFA.
|
|
|
|
Post by peppy on Sept 17, 2021 16:39:26 GMT -5
What happened? At the end of Friday. 3 million shares traded, real time and summary volume. added, After-Hours Volume 602,296. |
|
|
|
Post by prcgorman2 on Sept 18, 2021 7:57:27 GMT -5
What happened? At the end of Friday. 3 million shares traded, real time and summary volume. added, After-Hours Volume 602,296. Curiouser and curiouser... |
|
|
|
Post by markado on Sept 18, 2021 15:39:08 GMT -5
3 million shares traded, real time and summary volume. added, After-Hours Volume 602,296. Curiouser and curiouser... The 2nd rule of Wall Street? Be the first to panic. Is it close to time for shorts to panic? |
|
|
|
Post by mymann on Sept 19, 2021 14:51:56 GMT -5
Most of the biotechnology companies I follow had a spike in volume last 30min before closing Friday. Spike in mnkd volume appears to be a nothing burger.
|
|
|
|
Post by peppy on Sept 19, 2021 15:24:16 GMT -5
Most of the biotechnology companies I follow had a spike in volume last 30min before closing Friday. Spike in mnkd volume appears to be a nothing burger. Friday was September options expiration. |
|
|
|
Post by akemp3000 on Sept 19, 2021 17:48:26 GMT -5
Be prepared for the pre-PDUFA volatility. It should begin this week, next week at the latest. It may not be a binary moment in time for this company but it's sure as heck important as a positive outcome changes Mannkind from being a speculative biotech with no consistent revenue to a thriving young biotech with consistent revenue and a promising pipeline. As Peter Lynch famously said, know why you invest.
|
|
|
|
Post by prcgorman2 on Sept 20, 2021 6:23:19 GMT -5
Be prepared for the pre-PDUFA volatility. It should begin this week, next week at the latest. It may not be a binary moment in time for this company but it's sure as heck important as a positive outcome changes Mannkind from being a speculative biotech with no consistent revenue to a thriving young biotech with consistent revenue and a promising pipeline. As Peter Lynch famously said, know why you invest. I agree although I would say revenue from Afrezza has been surprisingly consistent, and of material importance. Even with COVID preventing in-person sales, Afrezza revenues were substantive and steady, although obviously still not profitable yet. (I didn’t bother looking at the income statement but I assume 2020 revenue from Afrezza was around $70M and that we’ll be near that number again this year.) |
|
|
|
Post by sportsrancho on Sept 20, 2021 6:38:32 GMT -5
Market down over 600 points. I think they’re trying to orchestrate a correction, mainly people are saying it’s because of the debt ceiling.
|
|
|
|
Post by akemp3000 on Sept 20, 2021 7:06:50 GMT -5
Thanks for pointing that out. In the past biotechs in general and MNKD in particular rarely followed the overall market as closely as other sectors. Recently though, MNKD seems to be following it more closely. This could make for an especially volatile period in the next three weeks.
|
|
|
|
Post by Clement on Sept 20, 2021 7:56:11 GMT -5
Be prepared for the pre-PDUFA volatility. It should begin this week, next week at the latest. It may not be a binary moment in time for this company but it's sure as heck important as a positive outcome changes Mannkind from being a speculative biotech with no consistent revenue to a thriving young biotech with consistent revenue and a promising pipeline. As Peter Lynch famously said, know why you invest. I agree although I would say revenue from Afrezza has been surprisingly consistent, and of material importance. Even with COVID preventing in-person sales, Afrezza revenues were substantive and steady, although obviously still not profitable yet. (I didn’t bother looking at the income statement but I assume 2020 revenue from Afrezza was around $70M and that we’ll be near that number again this year.) The 10K for 2020 shows that Afrezza net revenue for 2020 was $32.324 M. investors.mannkindcorp.com/static-files/c200a41e-04e9-4e86-a7d7-c74d7d1e237f |
|
|
|
Post by sportsrancho on Sept 20, 2021 7:58:17 GMT -5
Thanks for pointing that out. In the past biotechs in general and MNKD in particular rarely followed the overall market as closely as other sectors. Recently though, MNKD seems to be following it more closely. This could make for an especially volatile period in the next three weeks. This is my thinking, when we get this overall market selloff because the S&P is down below it’s 200 day the NASDAQ and everything else just follows suit and the more institutional investors we have the more up and downs we get because there’s an automatic selling that happens when certain technicals get crossed. I’m thinking it’ll be over by the end of the week:-) Or end of month. |
|
|
|
Post by Clement on Sept 20, 2021 8:16:39 GMT -5
The way I read Peppy's chart is that mnkd could go down 10% today and still be inside the wedge.
(re: Peppy's chart at the close on Sept 17)
|
|
|
|
Post by peppy on Sept 20, 2021 8:42:47 GMT -5
I see the humor.
MNKD is being bought.
325,662 in ten mins
Avg. Volume 2,950,038
MNKD had been running 300,000 the first hour the last month.
4.5100-0.0200 (-0.4415%)
As of 9:42AM EDT. Market open.
|
|
|
|
Post by Clement on Sept 20, 2021 8:47:09 GMT -5
down only 2 cents. lots of smart buyers this morning.
|
|
